Roxall

ROXALL Group is an international pharmaceutical company based in Hamburg, Germany. Our core business is pharmaceuticals for allergen immunotherapy – the only causal allergy therapy renowned by the World Health Organization (WHO) that not only has the capacity to prevent an allergy turning into asthma but can also block the growth of new sensitizations. At ROXALL, we strive to constantly improve our treatments and to manufacture the highest quality products. As a result, we have made several and many of the most important innovations in this field. ROXALL Group has subsidiaries in Europe, Asia and Latin America. The acquisition of the allergy-line of a pharmaceutical company in Bilbao, Spain, opened us a solid basis for future growth. Research in immuno- therapy has been the main focus of this company for more than 70 years. Our team in Bilbao works closely with leading research institutes, providing us with greater potential for developing new treatments. In addition to our allergen immune therapies, our subsidiary company DR. BECKMANN Pharma offers medical products that help ease many allergy symptoms. Our products range from nasal showers and ointments for sensitive skin to high quality allergen encasings and peak-flow meters.